Company / Accounts Receivable
MEDIFAST INC Accounts Receivable History
FY2014-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$584.0K
FY2020
5-year range
$584.0K / $1.4M
FY2016-FY2020
Trend
-59.4%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $1M to $584,000 over the past 2 years.
Based on SEC 10-K filings.
$584,000 in FY2020 with a 5-year CAGR of -18.6%.
Declined from $1M to $584,000 over the past 2 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +0.5%
- 5-Year CAGR
- -18.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -18.6%, indicating a declining trend.
- In FY2020, accounts receivable decreased 59.4% year-over-year.
- Peak accounts receivable was recorded in FY2014.
- Lowest accounts receivable in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 4.08 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2020 | $584.0K | -59.4% |
| FY2019 | $1.4M | +26.8% |
| FY2018 | $1.1M | +96.7% |
| FY2017 | $576.0K | -58.5% |
| FY2016 | $1.4M | -15.1% |
| FY2015 | $1.6M | -1.0% |
| FY2014 | $1.6M | +32.4% |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026